First H1N1 Swine Flu Vaccine, Replikins-Based, Is Ready Now for Testing Worldwide

LONDON, May 4, 2009 — A synthetic peptide H1N1 vaccine is available now for testing worldwide, from Replikins Ltd. The company has developed the vaccine based on the same Replikins peptide technology which provided the surprise advance warning one year ago that the current H1N1 outbreak/pandem…

Biotechnology Company, Replikins Ltd., Provided Advance Warning of Mexican H1N1 ‘Swine Flu’ Virus Outbreak

BOSTON, April 27, 2009 — Replikins Ltd. published a FluForecast(R) warning in April 7th, 2008, a year before the recent Mexico and California H1N1 cases. The company was able to state the likelihood of H1N1 outbreaks based on its patented Replikin Count(TM) genomics technology, which examines s…